Clinical Trial Update: L-Carnitine L-Tartrate in Preventing Peripheral Neuropathy Caused By Chemotherapy in Women With Metastatic Breast Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating L-Carnitine L-Tartrate for preventing peripheral neuropathy caused by chemotherapy in women with metastatic breast cancer; study termin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Chemotherapy-induced Neurotoxicity

Drugs mentioned

• L-Carnitine L-Tartrate (L-Carnitine L-Tartrate)

Snippet

Sponsor: HealthPartners Institute | Conditions: Breast Cancer, Chemotherapeutic Agent Toxicity | Phase 4 | Status: TERMINATED | Results posted: 2017-04-13